The company has been shamed by health regulators, lost revenue and is the center of hundreds of US lawsuits. Now it has thrown in a last-ditch effort to continue sales
More than a decade ago, Adam Bowen and James Monsees became friends over their smoke breaks at Stanford University. They were graduate students when they first conceived of the idea behind Juul: conventional cigarettes, like the ones they couldn’t stop smoking, were bad not because of nicotine, but for all the other chemicals from burnt tar.
The pair had a vision: design a device that would deliver solely nicotine, offer a better experience for smokers and help those who wanted to quit cigarettes.